Assura PLC
AGR
ISIN GB00BVGBWW93 / Valor 26446629
Assura PLC
UMushroom community rating:
About company
Assura PLC is a FTSE 250-listed real estate investment trust that specializes in designing, building, investing in, and managing GP surgery, primary care, and community healthcare buildings. The company focuses on providing the NHS with the necessary infrastructure to deliver a wide range of services, tests, and treatments in the community. Assura PLC plays a crucial role in supporting the healthcare sector by ensuring that healthcare facilities are well-equipped and maintained to meet the needs of patients and healthcare providers.
Summarized from source with an LLMView SourceSector: FinanceLatest Results (11.01.2025):
EPRA Earnings Growth
In the latest financial results for the quarter ending in 2024, Assura PLC reported a 6% increase in EPRA earnings, reaching £102.3 million compared to £96.8 million in the previous year. The EPRA earnings per share (EPS) also saw a slight increase to 3.4p from 3.3p.
Passing Rent Roll Increase
Assura PLC's passing rent roll increased by 5% in the latest quarter of 2024, amounting to £150.6 million, up from £143.4 million in 2023. The weighted average unexpired lease term (WAULT) stands at 10.8 years, indicating a stable and resilient asset base.
Net Rental Income
For the quarter ending in 2024, Assura PLC's net rental income rose by 4%, reaching £143.3 million compared to £138.0 million in the previous year. This growth reflects the company's strong performance in managing its property portfolio.
Dividend Increase
Assura PLC announced a 2.4% increase in its quarterly dividend, raising it to 0.84 pence per share, which translates to 3.36 pence on an annual basis. This increase will take effect from the July 2024 payment, demonstrating the company's commitment to returning value to shareholders.
IFRS Loss Before Tax
In the latest quarter of 2024, Assura PLC reported an IFRS loss before tax of £28.7 million, a significant improvement from the £119.2 million loss in 2023. The earnings per share (EPS) also improved to (1.0)p from (4.0)p, despite a 4% like-for-like valuation decline driven by an outward yield shift.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1541 M
Market cap (USD)
20,720,684
Daily traded volume (Shares)
0.381 / 0.3764
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
